Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
Weill Medical College of Cornell University
Weill Medical College of Cornell University
Eli Lilly and Company
Eli Lilly and Company
Turning Point Therapeutics, Inc.
University Hospital, Angers
AstraZeneca
AstraZeneca
Hoffmann-La Roche
AstraZeneca
VA Office of Research and Development
Essen Biotech
Eli Lilly and Company
Qilu Pharmaceutical Co., Ltd.
Institut du Cancer de Montpellier - Val d'Aurelle
Hoffmann-La Roche
Revolution Medicines, Inc.
Fundación GECP
Fundación GECP
Fundación GECP
Stanford University
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Nanfang Hospital, Southern Medical University
Weill Medical College of Cornell University
Hospices Civils de Lyon
University Hospital, Toulouse
Hoffmann-La Roche
Blueprint Medicines Corporation
Shanghai Yunying Medical Technology
Jiangsu HengRui Medicine Co., Ltd.
Revolution Medicines, Inc.
Syndax Pharmaceuticals
Fondation Hôpital Saint-Joseph
H. Lee Moffitt Cancer Center and Research Institute
University of Turin, Italy
University Hospital Tuebingen
Jiangsu HengRui Medicine Co., Ltd.
Shanghai Pulmonary Hospital, Shanghai, China
VA Office of Research and Development
University College London Hospitals
Shanghai Gebaide Biotechnology Co., Ltd.
Wuxi No. 4 People's Hospital
RWTH Aachen University
University Hospital, Angers
Valerio Therapeutics
NovaRx Corporation
Pharmacyclics LLC.
German Cancer Research Center
National Institutes of Health Clinical Center (CC)
Amsterdam UMC, location VUmc